Charles River Laboratories International (NYSE: CRL) is one of 196 publicly-traded companies in the “Biotechnology & Medical Research” industry, but how does it compare to its peers? We will compare Charles River Laboratories International to related businesses based on the strength of its earnings, valuation, dividends, institutional ownership, risk, analyst recommendations and profitability.

Valuation and Earnings

This table compares Charles River Laboratories International and its peers revenue, earnings per share (EPS) and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
Charles River Laboratories International $1.81 billion $435.89 million 28.35
Charles River Laboratories International Competitors $207.80 million -$2.19 million -0.33

Charles River Laboratories International has higher revenue and earnings than its peers. Charles River Laboratories International is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Analyst Ratings

This is a summary of recent ratings for Charles River Laboratories International and its peers, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Charles River Laboratories International 0 5 4 0 2.44
Charles River Laboratories International Competitors 790 2961 6462 145 2.58

Charles River Laboratories International presently has a consensus target price of $100.17, suggesting a potential downside of 7.27%. As a group, “Biotechnology & Medical Research” companies have a potential upside of 5.32%. Given Charles River Laboratories International’s peers stronger consensus rating and higher probable upside, analysts clearly believe Charles River Laboratories International has less favorable growth aspects than its peers.

Profitability

This table compares Charles River Laboratories International and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Charles River Laboratories International 10.13% 27.02% 8.84%
Charles River Laboratories International Competitors -3,686.40% -416.19% -47.54%

Institutional and Insider Ownership

95.4% of Charles River Laboratories International shares are held by institutional investors. Comparatively, 47.1% of shares of all “Biotechnology & Medical Research” companies are held by institutional investors. 2.2% of Charles River Laboratories International shares are held by insiders. Comparatively, 13.8% of shares of all “Biotechnology & Medical Research” companies are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Volatility and Risk

Charles River Laboratories International has a beta of 0.99, meaning that its share price is 1% less volatile than the S&P 500. Comparatively, Charles River Laboratories International’s peers have a beta of 1.67, meaning that their average share price is 67% more volatile than the S&P 500.

Summary

Charles River Laboratories International beats its peers on 7 of the 13 factors compared.

Charles River Laboratories International Company Profile

Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its clients from target identification through non-clinical development. The Company operates in three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment includes Research Models and Research Model Services. The DSA segment includes Discovery Services and Safety Assessment. The Manufacturing segment includes Microbial Solutions, Avian, Biologics and Contract Manufacturing. The Company also provides a suite of products and services to support the Company’s clients’ manufacturing activities.

Receive News & Stock Ratings for Charles River Laboratories International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Charles River Laboratories International Inc. and related stocks with our FREE daily email newsletter.